Quinidine: Clinical Trials

6 trials of Quinidine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 withdrawn. 6 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 36Completed 5, Withdrawn 1
Phase 21Withdrawn 1

Follow Quinidine: new trials by email Literature Review of Quinidine trials Research Report on Quinidine

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluating the Efficacy of Dextromethorphan/Quinidine in Treating Irritability in Huntington's Disease
Dextromethorphan/quinidine 20mg/10mg (DM/Q 20mg/10mg), Placebo - Huntington Disease, Irritability
Phase 3CompletedThe University of Texas Health Science Center, Houston202019-08-052024-01-05
Empiric Quinidine for Asymptomatic Brugada Syndrome
quinidine, no therapy - Arrhythmia
Phase 2 / Phase 3WithdrawnInternational Registry of Asymptomatic Brugada Syndrome2009-12-012020-02-13
Safety and Efficacy of AVP-923 in PBA Patients With ALS or MS
dextromethorphan hydrobromide 20 mg and quinidine sulfate 10 mg, dextromethorphan hydrobromide 30 mg and quinidine sulfate 10 mg, Placebo - Pseudobulbar Affect (PBA)
Phase 3CompletedAvanir Pharmaceuticals3262007-12-012017-04-12
Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM)
amiodarone, sotalol, propafenone - Arrhythmia, Atrial Fibrillation
Phase 3CompletedNational Heart, Lung, and Blood Institute (NHLBI)1995-03-012016-03-25
Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (CASCADE)
amiodarone, imipramine, mexiletine - Arrhythmia, Cardiovascular Diseases
Phase 3CompletedUniversity of Washington1987-04-012013-07-29
Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM)
electrophysiology, electrocardiography, ambulatory, imipramine - Arrhythmia, Cardiovascular Diseases
Phase 3CompletedUniversity of Utah1985-07-012016-01-21

Conditions studied

Arrhythmias, Cardiac (4)  ·  Cardiovascular Diseases (3)  ·  Heart Diseases (3)  ·  Ventricular Fibrillation (2)  ·  Amyotrophic Lateral Sclerosis (1)  ·  Atrial Fibrillation (1)  ·  Brugada Syndrome (1)  ·  Death, Sudden, Cardiac (1)  ·  Heart Arrest (1)  ·  Huntington Disease (1)  ·  Multiple Sclerosis (1)  ·  Myocardial Infarction (1)  ·  Tachycardia, Ventricular (1)

Sponsors

Avanir Pharmaceuticals (1)  ·  International Registry of Asymptomatic Brugada Syndrome (1)  ·  National Heart, Lung, and Blood Institute (NHLBI) (1)  ·  The University of Texas Health Science Center, Houston (1)  ·  University of Utah (1)  ·  University of Washington (1)

Countries

United States (3)  ·  Argentina (1)  ·  Brazil (1)  ·  Germany (1)  ·  Israel (1)  ·  Italy (1)  ·  Japan (1)  ·  Netherlands (1)

Top investigators

H. Greene (2)  ·  Adrian Hepner, M.D. (1)  ·  Erin L Furr Stimming, MD (1)  ·  Sami Viskin, M.D. (1)

Results publications

PMID 20839238, PMID 22032709, PMID 28974568, PMID 41499296

NIH funding

R01HL031472 (1), R01HL034071 (1)